CordenPharma
Brittany L. Hayes, Ph.D., is an accomplished professional in the pharmaceutical industry, currently serving as the Director of the Global Highly Potent & Oncology Platform at Corden Pharma. With a strong background in business development and applied technology, Brittany has held key leadership roles at Recro®, Regis Technologies, Thermo Fisher Scientific, and Patheon. Educationally, Brittany holds a Ph.D. in Organic Chemistry from Wake Forest University and a Bachelor of Science in Chemistry from Emory University.
This person is not in the org chart
This person is not in any offices
CordenPharma
1 followers
CordenPharma is your full-service partner in the Contract Development & Manufacturing (CDMO) of APIs, Lipid Excipients, Drug Products and Packaging. Through a network of cGMP facilities across Europe and the US organized under six technology platforms – Peptides, Lipids & Carbohydrates, Oligonucleotides, Injectables, Highly Potent & Oncology, Small Molecules - CordenPharma experts translate complex ideas, processes and projects at any stage of development into high-value pharmaceutical products. Visit to learn more > cordenpharma.com